Rocket Pharmaceuticals, Inc. Common Stock
Symbol: RCKT (NASDAQ)
3.91
▼ (-2.38%) -0.095
Company Description:
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
Key Stats
- Today's Open: $3.975
- Today's High: $3.975
- Today's Low: $3.905
- Today's Volume: 2.47K
- Yesterday Close: $4
- Yesterday High: $4.065
- Yesterday Low: $3.75
- Yesterday Volume: 2.41M
- Last Min Volume: 594
- Last Min High: $3.905
- Last Min Low: $3.905
- Last Min VWAP: $3.905
Company Profile
- Name: Rocket Pharmaceuticals, Inc. Common Stock
- Website: https://www.rocketpharma.com
- Listed Date: 2015-02-18
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001281895
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $431.62M
- Round Lot: 100
- Outstanding Shares: 107.90M
- Asset Type: CS
RECENT FILINGS FOR RCKT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-16 | 4 | View |
| 2025-10-14 | 144 | View |
| 2025-10-14 | 8-K | View |
| 2025-10-08 | 4 | View |
| 2025-10-03 | 4 | View |
| 2025-10-03 | 3 | View |
| 2025-10-03 | 8-K | View |
| 2025-10-03 | 8-K | View |
| 2025-09-29 | 8-K | View |
| 2025-09-23 | 4 | View |
| 2025-09-22 | 3 | View |
| 2025-09-17 | 8-K | View |
| 2025-09-09 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-08-27 | 4 | View |
| 2025-08-25 | 8-K | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
Latest News on RCKT